379 results
Page 8 of 19
424B5
6gxk8 vhata1
19 Mar 12
Prospectus supplement for primary offering
12:00am
424B5
z9fmwq 5j3hdkp
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
c2wsewob 0j8
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
8-K
bnebih7cx82
8 Feb 12
Entry into a Material Definitive Agreement
12:00am
8-K
q4fjtsmxzr5e
2 Feb 12
Other Events
12:00am
424B5
9kbl8389z3su0
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
lrwdp3gwb 972h9s
14 Dec 11
Entry into a Material Definitive Agreement
12:00am
8-K
qdeijk0knb4ic4xr
3 Aug 11
Results of Operations and Financial Condition
12:00am
8-K
io1aq luxhw
29 Jul 11
Other Events
12:00am
8-K
yzv0vdtf
9 Jun 11
Other Events
12:00am
8-K
jcljxrg
11 May 11
Results of Operations and Financial Condition
12:00am
8-K
9sen pw1ow6
22 Mar 11
Results of Operations and Financial Condition
12:00am
424B5
uetkkwt ucwu3jq
17 Feb 11
Prospectus supplement for primary offering
12:00am
424B5
5fmglnze6 4ck
15 Feb 11
Prospectus supplement for primary offering
12:00am
8-K
ao21 4yo60
9 Feb 11
Other Events
12:00am